Overcoming Challenges in Infectious Diseases
Discover the latest medical research on the prevention, management and treatment of infectious diseases.
LATEST TOPICS
-
Is diabetes a risk factor for herpes zoster?20 February, 2020In line with the results from a previous meta-analysis that evaluated several studies on herpes zoster (HZ),1 the findings from a literature review by a group of researchers in France demonstrate... -
Levofloxacin reduces mortality rate in myeloma4 February, 2020A randomised placebo-controlled trial that aimed to tackle early morbidity and mortality in myeloma (TEAMM) revealed that prophylactic levofloxacin reduces the risk of infection and death in... -
Clinical practice of community-acquired pneumonia (CAP) in emergency department29 January, 2020Prof. Zhu Hua Dong Director Emergency Department of Peking Union Medical College Hospital Vice Chairman Office Director Deputy Chairman of Emergency Medical Education Expert... -
Application of quinolones in the emergency department20 January, 2020Professor Zhao Xiaodong Chief physician and Department Director Emergency Department of The First Affiliated Hospital of PLA General Hospital of China (Hospital 304) Q1: What kind...
-
Combination Therapy of Medications from the Perspective of PK / PD9 January, 2020Professor Zhang Jing Chief Pharmacist Institute of Antibiotics, Huashan Hospital, Fudan University Director Key Laboratory of Clinical Pharmacology of Antibiotics, National Health... -
Sepsis: Early infectious disease consultation saves lives27 December, 2019A recent study on the acute management of patients with severe sepsis and septic shock revealed that infectious disease (ID) consultation within 12 hours after patients’ arrival at the hospital... -
Antibiotic resistance and the role of high-dose, short-course levofloxacin in the treatment of pneumonia23 December, 2019Associate Professor Dr Tran Van Ngoc, MD, PhD President of Ho Chi Minh City Respiratory Association Head of Respiratory Department of Cho Ray Hospital Excessive exposure to... -
The American Thoracic Society and Infectious Diseases Society of America update to the management of community-acquired pneumonia in adults – focus on antibiotic recommendations16 December, 2019The American Thoracic Society (ATS) and Infectious Diseases Society of America (IDSA) have recently published an update to the previous guidelines on the management of community-acquired... -
Sitafloxacin roles in the treatment of bacterial infections12 December, 2019Dr Sombat Leelasupasri, MD, PhD Infectious disease consultant, Phyathai II Hospital, Thailand Sitafloxacin, a fluoroquinolone, is a newer generation wide-spectrum antibiotic that... -
Interview on diagnosis and treatment of non-tuberculous mycobacterium infection28 November, 2019Prof Liu Yang Chief Physician, Institute of Antibiotics Executive Deputy Director of Outpatient Department Deputy Director of Medical Department Huashan Hospital (Affiliated to Fudan...
CONTENT LIBRARY
CONTENT LIBRARY
INTERVIEWS
-
Clinical practice of community-acquired pneumonia (CAP) in emergency department -
Application of quinolones in the emergency department -
Combination Therapy of Medications from the Perspective of PK / PD -
Antibiotic resistance and the role of high-dose, short-course levofloxacin in the treatment of pneumonia -
Sitafloxacin roles in the treatment of bacterial infections -
Interview on diagnosis and treatment of non-tuberculous mycobacterium infection -
High-dose, short-course levofloxacin versus conventional regimen for acute bacterial infection -
Recent update in the management of chronic obstructive pulmonary disease – an Asian perspective -
Levofloxacin: High-dose, short-course for bacterial infection -
2018 Taiwan’s pneumonia guidelines: What’s new?